Brent Longnecker Net Worth

The estimated Net Worth of Brent M Longnecker is at least $7.2 mil dollars as of 5 April 2021. Mr. Longnecker owns over 15,000 units of Genprex Inc stock worth over $7,200 and over the last 21 years he sold GNPX stock worth over $0. In addition, he makes $0 as Independent Director at Genprex Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Longnecker GNPX stock SEC Form 4 insiders trading

Brent has made over 1 trades of the Genprex Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 15,000 units of GNPX stock worth $62,250 on 5 April 2021.

The largest trade he's ever made was buying 15,000 units of Genprex Inc stock on 5 April 2021 worth over $62,250. On average, Brent trades about 2,500 units every 0 days since 2003. As of 5 April 2021 he still owns at least 15,000 units of Genprex Inc stock.

You can see the complete history of Mr. Longnecker stock trades at the bottom of the page.

Brent Longnecker biography

Brent M. Longnecker serves as Independent Director of the Company. Since September 2003, Mr. Longnecker has been the Chairman and Chief Executive Officer of Longnecker & Associates, an executive compensation and corporate governance consulting firm. From June 1999 to August 2003, Mr. Longnecker served as President of Resources Consulting Group, and Executive Vice President of Resources Connection. Mr. Longnecker has over 20 years of consulting experience, including as National Principal-In-Charge for the Performance Management and Compensation Consulting Practice of Deloitte & Touche and as partner at KPMG Peat Marwick. Mr. Longnecker’s consulting experience includes working with real estate companies, including publicly traded companies, on corporate governance issues and on the management of their assets. Mr. Longnecker holds Bachelor of Business Administration and MBA degrees from the University of Houston. He is a prolific author on the subjects of executive compensation and corporate governance.

How old is Brent Longnecker?

Brent Longnecker is 63, he's been the Independent Director of Genprex Inc since 2020. There are 4 older and 7 younger executives at Genprex Inc. The oldest executive at Genprex Inc is William Wilson, 70, who is the Independent Director.

What's Brent Longnecker's mailing address?

Brent's mailing address filed with the SEC is 3300 BEE CAVE ROAD, #650-227, AUSTIN, TX, 78746.

Insiders trading at Genprex Inc

Over the last 7 years, insiders at Genprex Inc have traded over $0 worth of Genprex Inc stock and bought 156,300 units worth $607,092 . The most active insiders traders include Ryan M. Confer, Christy M. Nance, eJack A Roth. On average, Genprex Inc executives and independent directors trade stock every 205 days with the average trade being worth of $14,575. The most recent stock trade was executed by John Rodney Varner on 21 April 2023, trading 19,000 units of GNPX stock currently worth $20,140.

What does Genprex Inc do?

genprex is mapping the future of cancer care. genprex's mission is to address the unmet medical needs of a growing population of cancer patients worldwide, through the development of a novel class of cancer drugs: immunogene therapy. our revolutionary clinical-stage products work synergistically with other approved and pipeline drugs to expand clinical indications for various cancers. about oncoprex® and lung cancer lung cancer is the second most common cancer in the u.s. but the leading cause of cancer death. there are approximately 225,000 new lung cancer cases in the u.s. per year and 1.8 million worldwide. the 5-year survival rate of stage iv non-small cell lung cancer (nsclc) is less than 1%, and treatment options beyond chemotherapy are lacking. approved nsclc targeted treatment options outside of chemo/radiation therapies only benefit a minority of patients. oncoprex® may now fill that gap by offering a targeted treatment option for a majority of nsclc patients. oncoprex® is cur

Complete history of Mr. Longnecker stock trades at Resources Connection Inc e Genprex Inc

Genprex Inc executives and stock owners

Genprex Inc executives and other stock owners filed with the SEC include:

• Ryan Confer,
  Chief Financial Officer
• John Rodney Varner,
  Co, Founder, Pres, CEO, Sec. & Chairman
• J. Rodney Varner,
  Chairman of the Board, President, Chief Executive Officer, Secretary
• Catherine M. Vaczy,
  Exec. VP, Gen. Counsel & Chief Strategy Officer
• Catherine M. Vaczy Esq.,
  Exec. VP, Gen. Counsel, Corp. Sec. & Chief Strategy Officer
• Ryan M. Confer M.S.,
  Chief Financial Officer
• William Wilson,
  Independent Director
• Jose Moreno Toscano,
  Independent Director
• Brent Longnecker,
  Independent Director
• Catherine Vaczy,
  Executive Vice President, Chief Strategy Officer
• Michael Redman,
  Chief Operating Officer, Executive Vice President
• David M. Schloss,
  Sr. VP of HR
• Greg Jancarik C.M.A., CPA, M.B.A.,
  Corp. Controller
• Dr. Mark S. Berger M.D.,
  Chief Medical Officer
• Dr. Hemant Kumar C.P.M., EMBA, Ph.D.,
  Chief Manufacturing & Technology Officer
• Dr. Jack A. Roth F.A.C.S., FACS, M.D.,
  Chairman of Scientific & Medical Advisory Board
• Dr. William E. Gannon Jr.,
  Member of Clinical Advisory Board & VP of Regulatory Affairs
• Thomas C. Gallagher Esq.,
  Sr. VP of Intellectual Property & Licensing
• Kalyn Dabbs,
  Sr. Mang. of Communications & Marketing
• Christy M. Nance,
  10% owner
• Jack A Roth,
  10% owner
• Viet An Hoan Ly,
  10% owner
• Inc. Genprex,,
  Chief Executive Officer
• Robert W. Pearson,
  Director
• David E. Friedman,
  Director
• Julien L Pham,
  President & COO
• Mark Stanley Berger,
  Chief Medical Officer
• Hermant Kumar,
  Chief Mfgr & Tech Officer